These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24803876)

  • 21. Hepatocellular carcinoma surveillance: An evidence-based approach.
    Harris PS; Hansen RM; Gray ME; Massoud OI; McGuire BM; Shoreibah MG
    World J Gastroenterol; 2019 Apr; 25(13):1550-1559. PubMed ID: 30983815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum protein biomarkers relevant to hepatocellular carcinoma and their detection.
    Waidely E; Al-Yuobi AR; Bashammakh AS; El-Shahawi MS; Leblanc RM
    Analyst; 2016 Jan; 141(1):36-44. PubMed ID: 26606739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic performance of tumor markers AFP and PIVKA-II in Chinese hepatocellular carcinoma patients.
    Huang S; Jiang F; Wang Y; Yu Y; Ren S; Wang X; Yin P; Lou J
    Tumour Biol; 2017 Jun; 39(6):1010428317705763. PubMed ID: 28621228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alternative Biomarkers to Predict Tumor Biology in Hepatocellular Carcinoma.
    Abreu P; Ferreira R; Mineli V; Ribeiro MA; Ferreira FG; DE Mello Vianna RM; Tomasich FDS; Szutan LA
    Anticancer Res; 2020 Dec; 40(12):6573-6784. PubMed ID: 33288552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The alpha-fetoprotein serum is still reliable as a biomarker for the surveillance of hepatocellular carcinoma in Indonesia.
    Jasirwan COM; Fahira A; Siregar L; Loho I
    BMC Gastroenterol; 2020 Jul; 20(1):215. PubMed ID: 32646378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biomarkers
    Balaceanu LA
    World J Clin Cases; 2019 Jun; 7(12):1367-1382. PubMed ID: 31363465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surveillance for hepatocellular carcinoma in chronic liver disease: evidence and controversies.
    van Meer S; de Man RA; Siersema PD; van Erpecum KJ
    World J Gastroenterol; 2013 Oct; 19(40):6744-56. PubMed ID: 24187450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of prothrombin induced by vitamin K absence, macrophage migration inhibitory factor and Golgi protein-73 versus alpha fetoprotein for hepatocellular carcinoma diagnosis and surveillance.
    Ismail MM; Morsi HK; Abdulateef NA; Noaman MK; Abou El-Ella GA
    Scand J Clin Lab Invest; 2017 May; 77(3):175-183. PubMed ID: 28276727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pitfalls in surveillance for hepatocellular carcinoma: How successful is it in the real world?
    Wong LL; Reyes RJ; Kwee SA; Hernandez BY; Kalathil SC; Tsai NC
    Clin Mol Hepatol; 2017 Sep; 23(3):239-248. PubMed ID: 28706177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Only one-third of hepatocellular carcinoma cases are diagnosed via screening or surveillance: a systematic review and meta-analysis.
    Zhao C; Xing F; Yeo YH; Jin M; Le R; Le M; Jin M; Henry L; Cheung R; Nguyen MH
    Eur J Gastroenterol Hepatol; 2020 Mar; 32(3):406-419. PubMed ID: 31490419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatocellular carcinoma.
    Marrero JA
    Curr Opin Gastroenterol; 2006 May; 22(3):248-53. PubMed ID: 16550039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The degree of readiness of selected biomarkers for the early detection of hepatocellular carcinoma: notes from a recent workshop.
    Block TM; Marrero J; Gish RG; Sherman M; London WT; Srivastava S; Wagner PD
    Cancer Biomark; 2008; 4(1):19-33. PubMed ID: 18334731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival.
    Santi V; Trevisani F; Gramenzi A; Grignaschi A; Mirici-Cappa F; Del Poggio P; Di Nolfo MA; Benvegnù L; Farinati F; Zoli M; Giannini EG; Borzio F; Caturelli E; Chiaramonte M; Bernardi M;
    J Hepatol; 2010 Aug; 53(2):291-7. PubMed ID: 20483497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surveillance for hepatocellular carcinoma: evidence, guidelines and utilization.
    Shoreibah MG; Bloomer JR; McGuire BM; Massoud OI
    Am J Med Sci; 2014 May; 347(5):415-9. PubMed ID: 24759379
    [No Abstract]   [Full Text] [Related]  

  • 35. Hepatocellular carcinoma surveillance, early detection and survival in a privately insured US cohort.
    Chen VL; Singal AG; Tapper EB; Parikh ND
    Liver Int; 2020 Apr; 40(4):947-955. PubMed ID: 31943689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening and surveillance for hepatocellular carcinoma: perspective of a new era?
    Maida M; Malizia G; Affronti A; Virdone R; Maida C; Margherita V; D'amico G
    Expert Rev Anticancer Ther; 2016 Dec; 16(12):1291-1302. PubMed ID: 27730841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Soluble cluster of differentiation 26/soluble dipeptidyl peptidase-4 and glypican-3 are promising serum biomarkers for the early detection of Hepatitis C virus related hepatocellular carcinoma in Egyptians.
    Gomaa SH; Abaza MM; Elattar HA; Amin GA; Elshahawy DM
    Arab J Gastroenterol; 2020 Dec; 21(4):224-232. PubMed ID: 32891543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Performance of protein induced by vitamin K absence or antagonist-II assessed by chemiluminescence enzyme immunoassay for hepatocellular carcinoma detection: a meta-analysis.
    Caviglia GP; Ribaldone DG; Abate ML; Ciancio A; Pellicano R; Smedile A; Saracco GM
    Scand J Gastroenterol; 2018 Jun; 53(6):734-740. PubMed ID: 29667463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma.
    Wen Y; Han J; Chen J; Dong J; Xia Y; Liu J; Jiang Y; Dai J; Lu J; Jin G; Han J; Wei Q; Shen H; Sun B; Hu Z
    Int J Cancer; 2015 Oct; 137(7):1679-90. PubMed ID: 25845839
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.